ClinicalTrials.gg
TerminatedNCT03987009HELP-VDLUpdated Feb 12, 2025

Do the Head-elevated Position and the Use of a Videolaryngoscope Facilitate Orotracheal Intubation in a Patient Population Without Predictable Difficulty of Intubation

An interventional study of Without RAMP and without video and With RAMP and with video in Anesthesia, sponsored by Hopital Foch. Terminated at 5 sites in France. Open to participants aged 18 Years to 89 Years. Per ClinicalTrials.gov, last updated 2025-02-12.

Sponsored by Hopital Foch · Not applicable, Interventional, and Other

Why this study was terminated
Discontinuation of DM production by the manufacturer leading to recruitment difficulties in the centers.
Phase
Not applicable
Study type
Interventional
Enrollment
121
Allocation
Randomized
Ages
18 Years to 89 Years
Sex
All
01

Study summary

The main hypothesis of this study is that there is a synergy between the use of the HELP position and the use of a McGrath® Mac videolaryngoscope to facilitate tracheal intubation during anesthesia.

The HELP position is the patient positioning on the AirPal RAMP, the two cushions inflated, bringing the external auditory canal to the same level as the sus-sternal notch.

Read the detailed description

Airway management remains an important determinant of morbidity and mortality in anesthesia, despite progress in recognizing factors of difficult mask ventilation and intubation. Many recommendations have been published regarding the practice of intubation in anesthesia. Our study focuses on two topics which remain under discussion: the position of the patient's head and the use of a videolaryngoscope.

As to patient's head position, most anesthesiologists place the patient in the sniffing position (supine torso with neck flexed forward, and head extended), a position denominated "sniffing"by analogy to that adopted to smell a perfume. However, Adnet et al. questioned this position based on magnetic resonance imaging of eight healthy young volunteers positioned either with their heads in a neutral position or in extension, or with their heads and necks on a pillow. They showed that the sniffing position does not allow the alignment of the three important axes (mouth, pharynx and larynx) in awake patients with normal airway anatomy [1]. The "Head Elevated Laryngoscopic position" (HELP), with a raise of the head and neck so that "An imaginary horizontal line should connect the patient's sternal notch with the external auditory meatus" [2] facilitates the alignment of the pharyngeal, laryngeal, and oral axes of the airway during difficult laryngoscopy [3].

As to videolaryngoscopy, there is no doubt that it is a major advance in airway management. A recent Cochrane Systematic Review concluded that videolaryngoscopy increased easy laryngeal views and reduced difficult views and intubation difficulty [4]. However, its place is still debated: first line or rescue in case of suspected difficult airway. Its systematic use means discarding the standard Macintosh laryngoscope [5] which is not supported by clinical studies, in particular those of Wallace et al. [6] and of Thion et al. [7].

In the present randomized study we will study a combination of two factors in tracheal intubation on patients without suspected airways abnormalities: position (sniffing or HELP) and a McGrath laryngoscope (with or without video). This leads to four groups, A: sniffing position plus McGrath Mac videolaryngoscope with its screen deactivated so as to mimic a plain laryngoscope (R-V-), B: HELP plus McGrath Mac videolaryngoscope with a deactivated video screen (R+V-), C: sniffing position plus a McGrath Mac videolaryngoscope with an activated video screen (R-V+), D: HELP plus a McGrath Mac videolaryngoscope with it video screen activated (R+V+). This protocol allows using the same type of laryngoscope in all cases.

02

Conditions studied

  • Anesthesia
03

In context

Lead sponsor

Hopital Foch is the lead sponsor of 215 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 89 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 - 89 years old
  • Scheduled for elective surgical procedures
  • Requiring oro-tracheal intubation for general anesthesia
  • Having a telephone and agreeing to communicate their phone number in case of ambulatory surgery
  • Having signed an informed consent form
  • Benefiting from a social insurance

Exclusion criteria

Exclusion Criteria:

  • Pregnant or breast-feeding women
  • Patients with an anticipated difficult mask ventilation or an anticipated difficult intubation (Arné's score ≥ 11)
  • Patients scheduled for a surgical procedure involving the mouth or the upper airway
  • Patients requiring a rapid induction sequence, the use of a double-lumen tube
  • Patients having a contra-indication to one of the drug administered by the protocol
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
121 participants (actual)

Study arms

  • Experimental
    Without RAMP and without video

    Sniffing position and a standard Macintosh laryngoscope

    Device: Without RAMP and without video

  • Experimental
    With RAMP and with video

    Ramped position and a McGrath Mac videolaryngoscope

    Device: With RAMP and with video

  • Experimental
    Without RAMP and with video

    Sniffing position and a McGrath Mac videolaryngoscope

    Device: Without RAMP and with video

  • Experimental
    With RAMP and without video

    Ramped position and a standard Macintosh laryngoscope

    Device: With RAMP and without video

Interventions

  • DeviceWithout RAMP and without video

    Intubation with video-laryngoscope McGrath without use of the video feature and patient positioning without RAMP device

  • DeviceWith RAMP and with video

    Intubation with video-laryngoscope McGrath with use of the video feature and patient positioning with RAMP device

  • DeviceWithout RAMP and with video

    Intubation with video-laryngoscope McGrath with use of the video feature and patient positioning without RAMP device

  • DeviceWith RAMP and without video

    Intubation with video-laryngoscope McGrath without use of the video feature and patient positioning with RAMP device

06

What researchers measure

Primary outcomes

  1. Proportion of oro-tracheal intubations for which it is necessary to use the assistance of a third party required by the operator

    Intubation is video and audio recorded. The number of people nedeed is determined from the audio/video recording a posteriori by two independent evaluators

    Time frame: 30 minutes

Secondary outcomes

  1. Time to perform the intubation

    Based on the video recording: from the passage the incisors to the third capnogram

    Time frame: 30 minutes

  2. First intubation succes rate

    Defined by repositioning of the videolaryngoscope blade in the patient's mouth

    Time frame: 30 minutes

  3. Assessment of the Quality of visualization of the glottis

    It is appreciated in real time by score of Cormak and Lehane modified by Yentis : from Grade 1 (glottis seen in totality) to Grade 4 (glottis hidden by epiglottis and tongue)

    Time frame: 30 minutes

  4. Assessment of the Percentage of the opening of the glottic orifice

    It is appreciated in real time POGO (Percentage of Opening of the Glottic orifice) score : from 0% (opening not visible) to 100% (all of the opening is visible)

    Time frame: 30 minutes

  5. Assessment of quality of intubation with use of alternative techniques

    Determined a posteriori from the video recording analysis

    Time frame: 30 minutes

  6. Occurrence of esophageal intubation

    Reported in real time by the operator during the video / audio recording

    Time frame: 30 minutes

  7. Number of tracheal intubation failure

    Number of tracheal intubation failure reported by the operator during the video / audio recording. Can be determined a posteriori from the video / audio recording.

    Time frame: 30 minutes

  8. Incidence of arterial oxygen desaturation (SpO2 < 92%)

    Valued in real time and reported by the operator during the video / audio recording.

    Time frame: 30 minutes

  9. Perception of difficulty in intubation

    Evaluation in real time based on a scale betwwen zero ( no difficulty) to ten (extremely difficult)

    Time frame: 30 minutes

  10. Cooperation of the various members of the anesthesia team

    Determined from the video / audio recording using Kraus Scale to evaluate cooperation and non-cooperation behaviors within the team. Positive rating: scale from 0 (never reported by the obsever) to 4 (obvious to the obsever). Negative rating: scale from 0 (nerver reported by the observer) to 4 (obvious most of the time for the observer)

    Time frame: 30 minutes

  11. Evolution of Blood pressure

    Blood pressure is monitored before the induction, before and after intubation.

    Time frame: 30 minutes

  12. Evolution of Heart beat

    Heart beat is monitored before the induction, before and after intubation.

    Time frame: 30 minutes

  13. Evaluation of frequency of intubation complications

    Number of events of Sore throat and voice change evaluated during postoperative visit on day 1 of the surgery

    Time frame: 24 hours

  14. Evaluation of severity of intubation complications

    Severity is evaluated during postoperative visit on day 1 of the surgery with 2 questions to the patient about his/her sore throat and voice change

    Time frame: 24 hours

07

Study locations

5 sites
  • Groupe Hospitalier Diaconesses Croix Saint Simon
    Paris, 75012, France
  • Hôpital Saint-Joseph
    Paris, 75014, France
  • Institut Mutualiste Montsouris
    Paris, 75014, France
  • Fondation Ophtalmologique Adolphe de Rothschild
    Paris, 75019, France
  • Hôpital Foch
    Suresnes, 92150, France
08

References and documents

Publications

  • Le Guen M, Coppere Z, Dufour G, Ouattara J, Trichereau J, Fischler M. HELP-VDL: study protocol for a multicentre, open, randomised, controlled clinical trial comparing the use of the head-elevated laryngoscopy position and the use of a videolaryngoscope to facilitate orotracheal intubation in a patient population without predictable difficulty of intubation. BMJ Open. 2020 Jul 8;10(7):e036570. doi: 10.1136/bmjopen-2019-036570. PubMed 32641332 ↗

Individual participant data

Plan to share: Yes — Data will be available in the Dryad repository.

Supporting information: Analytic code

Time frame: After publication in a peer-review journal. No limit in time

Access criteria: No criteria

Data sharing details ↗ · datadryad.org

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2019 to primary completion in Nov 2023, 51 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 7, 2019
First posted
Jun 14, 2019
StartActual
Jul 31, 2019
Primary completionActual
Nov 11, 2023
CompletionActual
Nov 11, 2023
Last update
Feb 12, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03987009
Lead sponsor
Hopital Foch
Responsible party
Sponsor
First posted
Jun 14, 2019
Start date
Jul 31, 2019
Primary completion
Nov 11, 2023
Completion
Nov 11, 2023
Last update
Feb 12, 2025

Study contacts

Morgan Le Guen, MD
principal investigator · Hôpital Foch

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion